| Literature DB >> 35378790 |
Rui Gao1,2, Guotai Yao1, Xiaolie Wang1, Yilin Wang1, Wenting Lin1, Liang Teng1, Yan Wang1, Yi Jin1, Zhongzhi Wang3, Jianghan Chen1,4.
Abstract
Aims: Cryptococcosis is an invasive fungal disease that is associated with an increasing prevalence along with a very high fatality and is primarily caused by Cryptococcus. However, its mechanism to cause pathogenicity is not yet completely understood. In this study, we aim to screen the lncRNA markers in human monocytic (THP-1) cells infected by Cryptococcus neoformans (C. neoformans) through high-throughput sequencing technology and to explore its effects on biological functions.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35378790 PMCID: PMC8976626 DOI: 10.1155/2022/5532118
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Quality statistics of different sample sequencing data.
| Sample | Raw data | Valid data | Valid ratio (%) | Q20 (%) | Q30 (%) | Mapped ratio (%) | ||
|---|---|---|---|---|---|---|---|---|
| Read | Base | Read | Base | |||||
| Case 1 | 100907820 | 10.09G | 97337470 | 9.73G | 96.46 | 99.65 | 93.62 | 96.75% |
| Case 3 | 100907820 | 10.14G | 97777644 | 9.78G | 96.47 | 99.77 | 94.53 | 97.22% |
| Case 5 | 111127214 | 11.11G | 107057624 | 10.71G | 96.34 | 99.73 | 94.29 | 97.03% |
| Control 2 | 127793504 | 12.78G | 123059382 | 12.31G | 96.3 | 99.72 | 93.95 | 97.00% |
| Control 4 | 129181238 | 12.92G | 124703732 | 12.47G | 96.53 | 99.79 | 95.11 | 97.42% |
| Control 6 | 111883148 | 11.19G | 107594368 | 10.76G | 96.17 | 99.57 | 93.04 | 96.47% |
Note: Case represents C. neoformans-infected THP-1 cells; control represents C. neoformans-uninfected THP-1 cells.
Figure 1The characteristic comparison of transcripts. (a) The distribution for exon number of lncRNAs along with mRNAs is given. (b) The expression level in addition to several lncRNAs besides mRNAs. (c) The distribution of varying length lncRNAs along with mRNAs has been given. (d) The distribution of lncRNAs along with mRNAs with varying length ORF. Moreover, mRNAs always carried longer ORF than lncRNAs. mRNA: messenger RNA; lncRNA: long noncoding RNA.
Figure 2lncRNAs along with mRNAs with their differential expression between THP-1 cells (n = 3) infected with Cryptococcus neoformans and uninfected control groups (n = 3). (a and b) Heat map of mRNA along with novel lncRNA expression. (c and d) Volcano plot of mRNA besides novel lncRNA expression; red dots depict upregulation of RNAs with P value < 0.05 along with a fold change ≥ 1, while blue dots illustrate downregulation of RNAs with P value < 0.05 along with a fold change ≤ −1. (e) Distribution of chromosomes for lncRNAs along with mRNAs with their differential expression are demonstrated, respectively, by the outer circle to the inner circle. Moreover, downregulation is represented by green, upregulation is represented by red, and gene enrichment is represented by the height of the bars. Case: C. neoformans-infected THP-1 cells; Control: normal THP-1 cells. (f and g) The top 10 differentially expressed mRNAs and lncRNAs for the real-time PCR validation of relative expression in C. neoformans (WM148)-infected THP-1 cells compared to controls. 0 h represents THP-1 cells without treated with WM148; 6 h represents THP-1 cells were treated with WM148 for 6 h. All results are expressed as mean ± SD from three independent experiments. ∗P < 0.05 and ∗∗P < 0.01 compared with the control group (0 h).
The 10 upregulated and downregulated mRNAs in C. neoformans-infected THP-1 cells.
| Upregulated mRNAs | Downregulated mRNAs | ||||
|---|---|---|---|---|---|
| Transcript ID |
| Log2 fold change (case vs. control) | Transcript ID |
| Log2 fold change (case vs. control) |
| ENSG00000278961 (SMIM34B) | 1.00 × 10−7 | 9.83 | ENSG00000181903 (OR4C6) | 1.40 × 10−3 | -9.3 |
| ENSG00000167244 (IGF2) | 2.33 × 10−3 | 7.26 | ENSG00000196844 (PATE2) | 2.87 × 10−4 | -9.17 |
| MSTRG.13124 (HIC1) | 4.69 × 10−3 | 4.32 | ENSG00000275385 (CCL18) | 6.71 × 10−4 | -9.16 |
| ENSG00000167723 (TRPV3) | 1.70 × 10−3 | 4.09 | ENSG00000119888 (EPCAM) | 2.80 × 10−3 | -8.93 |
| ENSG00000131721 (RHOXF2) | 3.57 × 10−3 | 3.49 | MSTRG.26977 (GCM2) | 1.05 × 10−3 | -8.32 |
| MSTRG.11170 (NRG4) | 1.28 × 10−7 | 2.92 | ENSG00000069535 (MAOB) | 6.80 × 10−3 | -8.31 |
| MSTRG.16004 (TIMM29) | 1.29 × 10−16 | 2.7 | ENSG00000102239 (BRS3) | 2.58 × 10−3 | -8.18 |
| MSTRG.295 (KAZN) | 1.22 × 10−4 | 2.33 | ENSG00000174460 (ZCCHC12) | 3.15 × 10−3 | -8.06 |
| MSTRG.10244 (CHRM5) | 1.26 × 10−4 | 2.28 | MSTRG.5103 (OR51M1) | 7.56 × 10−4 | -7.76 |
| MSTRG.17477 (ATP6V1C2) | 2.64 × 10−14 | 1.99 | ENSG00000187486 (KCNJ11) | 4.45 × 10−3 | -7.54 |
Note: Case represents C. neoformans-infected THP-1 cells; control represents C. neoformans-uninfected THP-1 cells.
The 10 upregulated and downregulated novel lncRNAs in C. neoformans-infected THP-1 cells.
| Upregulated lncRNAs | Downregulated lncRNAs | ||||
|---|---|---|---|---|---|
| Transcript ID |
| Log2 fold change (case vs. control) | Transcript ID |
| Log2 fold change (case vs. control) |
| MSTRG.22143 (ARIH2) | 1.98 × 10−3 | 14.69 | MSTRG.31823 (AC067930) | 1.18 × 10−10 | -16.37 |
| MSTRG.7645 (AC048341) | 5.74 × 10−4 | 14.66 | MSTRG.27113 (HIST1H2AC) | 4.58 × 10−10 | -14.68 |
| MSTRG.32644 (MFSD14C) | 1.87 × 10−17 | 14.64 | MSTRG.6371 (RDX) | 2.366 × 10−10 | -13.94 |
| MSTRG.14064 (VAT1) | 2.90 × 10−8 | 13.71 | MSTRG.1601 (DPYD-AS1) | 3.12 × 10−3 | -13.66 |
| MSTRG.13688 (NSRP1) | 7.49 × 10−8 | 13.48 | MSTRG.32392 | 3.78 × 10−3 | -13.65 |
| MSTRG.10709 (CCPG1) | 1.71 × 10−9 | 13.31 | MSTRG.27544 (BTBD9) | 1.49 × 10−9 | -13.55 |
| MSTRG.4158 (HERC4) | 3.79 × 10−10 | 13.08 | MSTRG.29230 (PSPHP1) | 7.93 × 10−9 | -13.42 |
| MSTRG.25409 (GPBP1) | 6.13 × 10−9 | 13.04 | MSTRG.7357 (TMBIM6) | 2.31 × 10−8 | -13.37 |
| MSTRG.11060 (PKM) | 9.82 × 10−8 | 12.99 | MSTRG.26157 (AC010240) | 2.26 × 10−9 | -13.36 |
| MSTRG.30097 (EXOC4) | 9.56 × 10−10 | 12.96 | MSTRG.11028 (PIAS1) | 2.92 × 10−16 | -13.3 |
Note: Case represents C. neoformans-infected THP-1 cells; control represents C. neoformans-uninfected THP-1 cells.
Figure 3Analyses of GO along with KEGG for the differential mRNA expression profile. (a) GO and (b) KEGG.
Figure 4Cis-regulation network of mRNA and lncRNA with Pearson′s correlation > 0.8 or < −0.8. Red dot represents mRNA, and blue dot represents lncRNA.